These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 522203

  • 1. [Action of medium-size molecules at the cell respiration level in hemodialysis patients].
    Murisasco A, Saingra S, Crevat A, Rinaudo JB, Gallice P.
    J Urol Nephrol (Paris); 1979 Sep; 85(9):586-9. PubMed ID: 522203
    [No Abstract] [Full Text] [Related]

  • 2. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
    Rinaudo JB, Gallice P, Crevat A, Saingra S, Murisasco A.
    Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
    [Abstract] [Full Text] [Related]

  • 3. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
    Kozlov VV, Riabov SI, Dorofeeva TB, von Appen K, Spiridonov VN.
    Ter Arkh; 1984 Oct; 56(7):77-81. PubMed ID: 6484840
    [No Abstract] [Full Text] [Related]

  • 4. [Hypothesis of medium-size molecules in clinical nephrology].
    Gabriélian NI, Levitskiĭ ER, Shcherbaneva OI, Poriadin NF, Savost'ianova OA.
    Ter Arkh; 1983 Oct; 55(6):76-8. PubMed ID: 6351329
    [No Abstract] [Full Text] [Related]

  • 5. [Concentration of medium molecular weight components in serum and ultrafiltrate in patients with chronic renal failure].
    Popławski A.
    Pol Tyg Lek; 1983 Oct; 46(40-42):750-2. PubMed ID: 1669151
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Analysis of middle molecules in patients undergoing hemodialysis therapy].
    Gabriélian NI, Levitskiĭ ER, Zhigalkin VN, Gorbunov VV, Korsakov VB.
    Ter Arkh; 1983 Oct; 55(11):107-10. PubMed ID: 6658647
    [No Abstract] [Full Text] [Related]

  • 8. [Serum myoglobin levels in patients with acute and chronic renal insufficiency].
    Stefanović V, Miljković P, Lecić N, Bogićević M.
    Srp Arh Celok Lek; 1989 Oct; 117(5-6):301-11. PubMed ID: 2595459
    [Abstract] [Full Text] [Related]

  • 9. What influences the level of oxidative stress as measured by 8-hydroxy-2'-deoxyguanosine in patients on hemodialysis?
    Mastalerz-Migas A, Steciwko A, Pokorski M, Pirogowicz I, Drobnik J, Bunio A, Muszyńska A, Jasińska A.
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():199-205. PubMed ID: 17072047
    [Abstract] [Full Text] [Related]

  • 10. [Clinical role of middle-size molecules in the pathogenesis of nephrogenic anemia].
    Gudim VI, Sigalla P, Devo Z, Ivanova VS, Gorbunova NA.
    Ter Arkh; 1983 Sep; 55(6):78-82. PubMed ID: 6612625
    [No Abstract] [Full Text] [Related]

  • 11. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M, Mircescu G, Cîrjan C, Mihăilescu I, Gîrneaţă L, Ursea N, Dinu V.
    Rom J Intern Med; 1995 Sep; 33(3-4):237-42. PubMed ID: 8646196
    [Abstract] [Full Text] [Related]

  • 12. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI, Gorbunova NA.
    Ter Arkh; 1997 Sep; 69(7):46-50. PubMed ID: 9424758
    [Abstract] [Full Text] [Related]

  • 13. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK, Dogukan A, Yalniz M, Seckin D, Gunal AL.
    Ren Fail; 2006 Sep; 28(8):723-7. PubMed ID: 17162433
    [Abstract] [Full Text] [Related]

  • 14. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 15. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI, Braga Lopes C, Magalhães CA, Schleicher CC, Veiga JP.
    Life Sci; 2005 Nov 04; 77(25):3141-55. PubMed ID: 16005905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients].
    Wang HT, Peng YM, Liu H.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 04; 28(3):266-8. PubMed ID: 14653086
    [Abstract] [Full Text] [Related]

  • 18. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F.
    Nefrologia; 2005 Jun 04; 25 Suppl 2():15-8. PubMed ID: 16050396
    [Abstract] [Full Text] [Related]

  • 19. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C, Heintz B, Sieberth HG.
    Clin Nephrol; 1999 Nov 04; 52(5):312-21. PubMed ID: 10584995
    [Abstract] [Full Text] [Related]

  • 20. Free phenols in chronic renal failure.
    Wardle EN, Wilkinson K.
    Clin Nephrol; 1976 Aug 04; 6(2):361-4. PubMed ID: 954243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.